Log in to your Inderes Free account to see all free content on this page.
ExpreS2ion Biotech Holding
5.05 SEK
-4.72 %
Less than 1K followers
EXPRS2
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for ExpreS2ion Biotech Holding
EV/S
Median 2019-2022
P/B
Median 2019-2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Share price (SEK) | 111.29 | 337.85 | 1,139.38 | 525.48 | 72.13 | 20.60 | 15.90 |
| Shares | 0.5 | 0.5 | 0.9 | 1.1 | 1.5 | 2.7 | 3.5 |
| Market cap | 52.8 | 173.6 | 1,074.9 | 580.1 | 108.5 | 54.8 | 56.1 |
| Enterprise value | 53.9 | 68.7 | 937.9 | 470.9 | - | - | - |
| EV/S | 3.9 | 4.5 | 76.7 | 92.5 | - | - | - |
| EV/EBITDA | neg. | neg. | neg. | neg. | - | - | - |
| EV/EBIT | neg. | neg. | neg. | neg. | - | - | - |
| P/E | neg. | neg. | neg. | neg. | neg. | neg. | neg. |
| P/B | -48.91 | 1.84 | 7.66 | 5.61 | 1.78 | 0.85 | 1.57 |
| P/S | 3.8 | 11.4 | 87.9 | 114.0 | 15.4 | 18.2 | 15.3 |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
| Equity ratio | -5.8 % | 79.6 % | 92.4 % | 75.2 % | 82.0 % | 61.6 % | 54.8 % |
| Gearing ratio | -601.8 % | 2.0 % | 1.4 % | 1.7 % | 0.5 % | 0.6 % | 1.4 % |
Login required
This content is only available for logged in users